SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-006824
Filing Date
2020-10-02
Accepted
2020-10-02 15:39:59
Documents
6
Period of Report
2020-09-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_100220.htm 8-K 31473
2 EXHIBIT 3.1 exh_31.htm EX-3.1 188039
3 EXHIBIT 99.1 exh_991.htm EX-99.1 22608
4 EXHIBIT 99.2 exh_992.htm EX-99.2 6849
5 logo.jpg GRAPHIC 8022
6 exh992small_1.jpg GRAPHIC 3298
  Complete submission text file 0001171843-20-006824.txt   266075
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 201219774
SIC: 2834 Pharmaceutical Preparations